Obesity May Give Men With Melanoma a Survival Advantage

Obesity May Give Men With Melanoma a Survival Advantage

Obese men with advanced melanoma skin cancer seem to have a survival benefit over their slimmer peers, a new study suggests.

Sign Up & Receive Your Personalized MedCircle Digest Delivered To Your Inbox.
Join today!

Among men who received treatment for the potentially deadly cancer, obese patients lived an average of 47 percent longer than those with a healthy body weight, researchers found.

For women, however, weight did not affect survival, according to the study.

"The question is, what underlying mechanism causes this advantage in obese men, and can we take advantage of it to improve outcomes in patients with melanoma?" said the study's lead author, Dr. Jennifer McQuade. She's an instructor of melanoma medical oncology at the University of Texas MD Anderson Cancer Center.

"One hint may be the interaction between obesity, sex and outcomes, which has not been detected before in any cancer," McQuade said in a news release from the cancer center.

It's long been known that women with advanced melanoma live longer than men with the disease. The researchers said their finding that obesity overcomes this survival disadvantage for men will lead them to examine the role of sex hormones.

The study involved about 1,900 people whose advanced melanoma was treated with targeted therapy, immunotherapy or chemotherapy. Overall, obese men lived from about 27 to 37 months after treatment, depending on the treatment, compared with 14 to 20 months for men of normal weight. Women lived about 33 months after treatment, regardless of their weight, the study found.

Although the study found an association between weight and survival after melanoma treatment in men, it did not prove a cause-and-effect relationship.

"The public health message is not that obesity is good. Obesity is a proven risk factor for many diseases," McQuade stressed.

Sign Up & Receive Your Personalized MedCircle Digest Delivered To Your Inbox.
Join today!

"Even within our metastatic melanoma population, we would not suggest that patients intentionally gain weight," she said. "We need to figure out what is driving this paradox and learn how to use this information to benefit all of our patients."

The findings were published online Feb. 12 in The Lancet Oncology.

More information

The U.S. National Cancer Institute has more on melanoma.


Copyright © 2013-2018 HealthDay. All rights reserved.


Related Content

Can Smartphones Trigger ADHD Symptoms in Teens?
Can Smartphones Trigger ADHD Symptoms in Teens?

Teenagers who constantly use their smartphones may have a heightened risk of dev...

Read more
Brain Scans Yield More Clues to Autism
Brain Scans Yield More Clues to Autism

Children with autism show abnormalities in a deep brain circuit that typically m...

Read more
How the Office Seating Chart Affects Your Productivity
How the Office Seating Chart Affects Your Productivity

In my days working in an office, I was always most content when I worked by a wi...

Read more
What Your Social Media Posts Say About Your Drinking Habits
What Your Social Media Posts Say About Your Drinking Habits

Picture this: It’s the Friday afternoon of what has been a particularly stressfu...

Read more
Alzheimer's Risk 10 Times Lower With Herpes Medication
Alzheimer's Risk 10 Times Lower With Herpes Medication

Last month, Medical News Today reported on a study that found "strong evidence" ...

Read more